Header Logo

Sonal Singh

Concepts (670)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypoglycemic Agents
15
2021
192
3.680
Why?
Diabetes Mellitus, Type 2
19
2018
635
3.400
Why?
Cough
13
2021
182
3.360
Why?
Pulmonary Disease, Chronic Obstructive
15
2014
655
3.010
Why?
Thiazolidinediones
10
2015
50
2.930
Why?
Cardiovascular Diseases
15
2017
788
2.530
Why?
Scopolamine Derivatives
9
2014
13
2.470
Why?
Drug-Related Side Effects and Adverse Reactions
6
2024
140
2.330
Why?
Cholinergic Antagonists
7
2024
33
2.160
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8
2019
206
2.070
Why?
Warfare
12
2014
33
2.060
Why?
Humans
186
2025
59160
2.040
Why?
Gastrointestinal Hemorrhage
5
2020
78
2.000
Why?
Randomized Controlled Trials as Topic
25
2024
675
1.890
Why?
Pancreatitis
7
2015
95
1.870
Why?
Drugs, Generic
3
2018
16
1.730
Why?
Alzheimer Disease
4
2024
680
1.580
Why?
Algorithms
6
2022
974
1.440
Why?
Dabigatran
5
2023
20
1.430
Why?
Decision Support Techniques
5
2020
178
1.420
Why?
Delivery of Health Care
7
2021
407
1.410
Why?
Adverse Drug Reaction Reporting Systems
4
2017
45
1.380
Why?
Adrenal Cortex Hormones
5
2018
168
1.260
Why?
Anticoagulants
10
2023
475
1.260
Why?
Pneumonia
6
2018
279
1.240
Why?
Research Design
11
2023
556
1.180
Why?
Benzazepines
3
2012
21
1.150
Why?
Quinoxalines
3
2012
35
1.120
Why?
Inappropriate Prescribing
2
2024
64
1.100
Why?
Aortic Aneurysm
2
2018
80
1.100
Why?
Myocardial Ischemia
3
2014
111
1.090
Why?
Myocardial Infarction
9
2018
859
1.090
Why?
United States Food and Drug Administration
5
2018
86
1.090
Why?
Bronchodilator Agents
4
2014
122
1.060
Why?
Clinical Trials as Topic
9
2018
441
1.050
Why?
Aged
40
2025
13354
1.030
Why?
Administration, Inhalation
12
2014
145
1.030
Why?
Evidence-Based Medicine
8
2019
443
1.030
Why?
Male
57
2025
27632
1.010
Why?
Female
63
2025
30622
0.970
Why?
Warfarin
6
2015
104
0.970
Why?
Risk Assessment
19
2020
1898
0.940
Why?
Atrial Fibrillation
6
2023
805
0.940
Why?
Dementia
2
2024
248
0.930
Why?
Renal Insufficiency
2
2023
65
0.930
Why?
Glucagon-Like Peptide 1
3
2018
23
0.890
Why?
Ipratropium
3
2014
7
0.860
Why?
Human Rights
5
2008
17
0.860
Why?
Nicotinic Agonists
3
2012
39
0.850
Why?
Asthma
2
2022
452
0.840
Why?
Anti-Bacterial Agents
4
2018
731
0.840
Why?
Primary Prevention
3
2019
134
0.810
Why?
Electronic Health Records
3
2022
342
0.810
Why?
Adult
38
2025
15625
0.800
Why?
Anti-Asthmatic Agents
1
2022
29
0.800
Why?
Periodicals as Topic
2
2020
167
0.790
Why?
Antibodies, Monoclonal, Humanized
2
2024
219
0.790
Why?
Prescription Drugs
3
2018
47
0.780
Why?
Renal Insufficiency, Chronic
1
2023
113
0.760
Why?
Early Detection of Cancer
2
2025
266
0.760
Why?
Review Literature as Topic
5
2016
33
0.750
Why?
Heart Failure
7
2016
852
0.740
Why?
Biological Products
1
2022
90
0.730
Why?
Middle Aged
40
2025
16251
0.730
Why?
Antiparkinson Agents
1
2021
10
0.720
Why?
Dopamine Antagonists
1
2021
15
0.720
Why?
Fluoroquinolones
2
2018
31
0.710
Why?
HIV Infections
9
2017
912
0.690
Why?
Public Health
3
2007
174
0.680
Why?
Nepal
13
2016
93
0.680
Why?
Tiotropium Bromide
8
2014
17
0.670
Why?
Lung Neoplasms
3
2025
583
0.670
Why?
Pharmaceutical Preparations
1
2021
117
0.660
Why?
Vaccination Coverage
1
2019
7
0.660
Why?
Practice Guidelines as Topic
6
2018
703
0.660
Why?
Hospitalization
5
2022
1288
0.660
Why?
Intracranial Hemorrhages
1
2020
61
0.660
Why?
Wernicke Encephalopathy
4
2007
4
0.650
Why?
Risk Factors
20
2018
4949
0.650
Why?
Drug Prescriptions
1
2021
168
0.650
Why?
Testosterone
2
2016
112
0.640
Why?
Decision Making
4
2025
394
0.630
Why?
Treatment Outcome
17
2023
5227
0.630
Why?
Human Rights Abuses
3
2007
3
0.620
Why?
Cardiovascular System
1
2019
38
0.610
Why?
beta-Alanine
2
2015
8
0.610
Why?
Glucocorticoids
2
2011
179
0.610
Why?
Databases, Factual
5
2021
805
0.610
Why?
Myocarditis
1
2019
60
0.600
Why?
Immunologic Factors
1
2019
102
0.600
Why?
Thiophenes
2
2015
29
0.600
Why?
Death, Sudden, Cardiac
2
2019
349
0.600
Why?
Refugees
4
2008
66
0.600
Why?
Patient Participation
1
2020
216
0.590
Why?
Cause of Death
3
2019
207
0.590
Why?
Morpholines
2
2015
86
0.590
Why?
Urinary Bladder Neoplasms
2
2015
62
0.590
Why?
Stroke
6
2023
1124
0.590
Why?
United States
18
2023
7378
0.580
Why?
Statistics as Topic
1
2018
145
0.580
Why?
Benzimidazoles
2
2015
56
0.580
Why?
Amphetamine
1
2017
11
0.570
Why?
Herpes Zoster
1
2017
23
0.560
Why?
Aged, 80 and over
13
2024
5104
0.560
Why?
Guidelines as Topic
4
2012
153
0.550
Why?
Thyroxine
1
2017
52
0.550
Why?
Atherosclerosis
1
2018
146
0.550
Why?
Incretins
1
2016
7
0.550
Why?
Incidence
9
2022
1225
0.540
Why?
Antithrombins
1
2017
14
0.540
Why?
Cerebrovascular Disorders
1
2017
73
0.540
Why?
Disasters
2
2014
28
0.530
Why?
Communication
5
2025
548
0.520
Why?
Health Services Accessibility
6
2009
521
0.510
Why?
Bronchitis
2
2020
27
0.510
Why?
Pharyngitis
2
2006
12
0.500
Why?
Streptococcus pyogenes
2
2006
27
0.500
Why?
Arrhythmias, Cardiac
2
2016
144
0.490
Why?
Rhabdomyolysis
2
2006
21
0.490
Why?
Fluorobenzenes
2
2005
5
0.490
Why?
Streptococcal Infections
2
2006
76
0.480
Why?
Patient Education as Topic
3
2024
452
0.480
Why?
Fractures, Bone
3
2011
135
0.470
Why?
Pharmacoepidemiology
1
2014
7
0.470
Why?
Risk
7
2020
364
0.470
Why?
Vena Cava Filters
2
2014
21
0.470
Why?
Heptanoic Acids
2
2004
20
0.470
Why?
Pyrroles
2
2004
45
0.460
Why?
Pyrimidines
2
2005
129
0.450
Why?
Sulfonamides
2
2005
120
0.450
Why?
Embolism, Paradoxical
1
2014
13
0.440
Why?
Medication Adherence
2
2015
239
0.440
Why?
Developing Countries
4
2008
85
0.440
Why?
Azasteroids
1
2013
1
0.430
Why?
Urinary Retention
2
2011
31
0.430
Why?
5-alpha Reductase Inhibitors
1
2013
6
0.430
Why?
Bariatric Surgery
3
2013
52
0.430
Why?
Age Factors
8
2021
1497
0.430
Why?
Health Planning Guidelines
1
2013
31
0.430
Why?
Valproic Acid
1
2013
26
0.430
Why?
Mass Screening
3
2025
646
0.420
Why?
Antipsychotic Agents
3
2024
292
0.420
Why?
Relief Work
3
2007
12
0.420
Why?
Dose-Response Relationship, Drug
6
2014
806
0.420
Why?
Consensus
3
2018
195
0.420
Why?
Biomedical Research
3
2013
248
0.420
Why?
Vaccination
6
2025
333
0.420
Why?
Child Development Disorders, Pervasive
1
2013
45
0.420
Why?
Physician-Patient Relations
3
2025
395
0.410
Why?
Meta-Analysis as Topic
5
2015
77
0.410
Why?
Anticonvulsants
1
2013
88
0.410
Why?
Insulin
1
2016
674
0.410
Why?
Tomography, X-Ray Computed
1
2020
1514
0.410
Why?
Prostatic Neoplasms
1
2015
325
0.400
Why?
Pancreatic Neoplasms
1
2015
331
0.400
Why?
Diagnostic Techniques and Procedures
1
2012
9
0.400
Why?
Tobacco Use Cessation
1
2012
29
0.390
Why?
Epilepsy
1
2013
106
0.390
Why?
Polypharmacy
2
2024
61
0.390
Why?
Chronic Disease
6
2021
713
0.390
Why?
Macular Edema
1
2012
24
0.390
Why?
Cohort Studies
5
2021
2369
0.390
Why?
Prenatal Exposure Delayed Effects
1
2013
151
0.380
Why?
Bupropion
1
2011
8
0.380
Why?
Acute Disease
6
2020
656
0.380
Why?
Diabetic Angiopathies
2
2008
24
0.380
Why?
Physicians
4
2025
424
0.370
Why?
Mucociliary Clearance
1
2021
6
0.370
Why?
Wounds and Injuries
1
2014
229
0.370
Why?
Reflex
1
2021
27
0.370
Why?
Venoms
3
2016
11
0.370
Why?
Administration, Oral
5
2023
355
0.360
Why?
Opportunistic Infections
1
2011
29
0.360
Why?
Autistic Disorder
1
2013
145
0.360
Why?
Dipeptidyl-Peptidase IV Inhibitors
4
2021
10
0.360
Why?
Nicotine
1
2011
112
0.350
Why?
Product Surveillance, Postmarketing
4
2012
20
0.340
Why?
Reproducibility of Results
4
2022
1558
0.340
Why?
Respiratory Tract Infections
1
2011
84
0.340
Why?
Bronchitis, Chronic
1
2020
16
0.340
Why?
Lower Extremity
3
2021
145
0.340
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2011
201
0.340
Why?
Suicide
1
2011
117
0.340
Why?
Eosinophilia
1
2020
29
0.330
Why?
Child
11
2020
4163
0.330
Why?
Quality of Life
3
2020
1135
0.330
Why?
Retrospective Studies
10
2023
6035
0.330
Why?
Primary Health Care
3
2024
644
0.330
Why?
International Cooperation
5
2008
84
0.320
Why?
Outpatients
2
2020
136
0.320
Why?
Mortality
3
2018
154
0.320
Why?
Glucagon-Like Peptide-1 Receptor
2
2021
19
0.320
Why?
Depression
3
2014
827
0.320
Why?
Kidney Failure, Chronic
2
2008
206
0.310
Why?
Diphosphonates
1
2009
31
0.310
Why?
Observational Studies as Topic
3
2019
55
0.310
Why?
Health
2
2006
31
0.310
Why?
Outsourced Services
1
2008
3
0.310
Why?
Pregnancy Complications
1
2013
364
0.310
Why?
Polyethylene Glycols
2
2023
165
0.310
Why?
Whooping Cough
1
2018
9
0.310
Why?
Postoperative Complications
4
2013
1184
0.310
Why?
Gastroesophageal Reflux
1
2019
81
0.310
Why?
Bone Density Conservation Agents
1
2009
44
0.310
Why?
Publication Bias
4
2012
20
0.310
Why?
Emigration and Immigration
2
2008
25
0.300
Why?
Bronchiolitis, Viral
1
2018
4
0.300
Why?
Young Adult
8
2025
4254
0.300
Why?
Disaster Planning
3
2015
49
0.300
Why?
Qualitative Research
5
2025
618
0.300
Why?
Stomatitis
1
2008
7
0.290
Why?
Adolescent
9
2020
5813
0.290
Why?
Attitude to Health
2
2008
279
0.290
Why?
Simvastatin
2
2005
26
0.290
Why?
Antiviral Agents
2
2023
311
0.290
Why?
Hemorrhage
3
2023
260
0.290
Why?
Secondary Prevention
2
2019
151
0.290
Why?
Interferon-alpha
1
2008
99
0.280
Why?
Civil Disorders
1
2007
2
0.280
Why?
Patient Advocacy
1
2007
38
0.280
Why?
Peptides
3
2016
547
0.280
Why?
Lisinopril
1
2006
4
0.270
Why?
Lung Diseases, Interstitial
1
2018
129
0.270
Why?
Child Welfare
2
2009
52
0.270
Why?
Critical Illness
1
2020
327
0.270
Why?
Renal Dialysis
1
2008
189
0.260
Why?
Contrast Media
2
2008
407
0.260
Why?
Tuberculosis, Pulmonary
1
2017
108
0.260
Why?
Sample Size
4
2023
61
0.260
Why?
Information Dissemination
1
2007
113
0.260
Why?
Smoking Cessation
1
2011
542
0.260
Why?
Amiodarone
1
2006
20
0.260
Why?
Pulmonary Alveoli
1
2006
44
0.260
Why?
Hydralazine
1
2006
1
0.260
Why?
Influenza, Human
1
2018
191
0.260
Why?
Self Care
1
2008
207
0.260
Why?
Clinical Clerkship
1
2006
89
0.260
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2006
142
0.250
Why?
Vasodilator Agents
1
2006
62
0.250
Why?
Internal Medicine
1
2006
149
0.250
Why?
Religion and Medicine
1
2005
17
0.250
Why?
Vasoconstrictor Agents
1
2006
64
0.250
Why?
Myelography
1
2005
4
0.240
Why?
Iopamidol
1
2005
13
0.240
Why?
Aging
1
2021
710
0.240
Why?
Prospective Studies
3
2024
3052
0.240
Why?
Anti-Arrhythmia Agents
1
2006
96
0.240
Why?
Cocaine-Related Disorders
1
2006
82
0.240
Why?
Patient Selection
5
2015
458
0.240
Why?
Religion
1
2005
29
0.240
Why?
Bariatrics
1
2005
1
0.240
Why?
Community Health Services
1
2006
120
0.240
Why?
Pharynx
1
2005
21
0.240
Why?
Cocaine
1
2006
96
0.240
Why?
Carotid Stenosis
1
2006
103
0.240
Why?
Disease Outbreaks
1
2005
101
0.240
Why?
Aminopyridines
2
2016
31
0.240
Why?
Peripheral Nervous System Diseases
1
2005
26
0.240
Why?
Formularies as Topic
1
2004
1
0.240
Why?
Lymphoma, T-Cell, Cutaneous
1
2024
8
0.240
Why?
Patient-Centered Care
2
2019
246
0.240
Why?
Benzamides
2
2016
63
0.230
Why?
Deprescriptions
1
2024
24
0.230
Why?
Hypnotics and Sedatives
1
2024
62
0.230
Why?
Referral and Consultation
1
2008
398
0.230
Why?
Lung Diseases
1
2006
169
0.230
Why?
Social Justice
1
2004
29
0.230
Why?
Societies, Medical
1
2006
333
0.230
Why?
Seizures
1
2005
115
0.230
Why?
Lupus Erythematosus, Systemic
1
2006
158
0.230
Why?
Follow-Up Studies
4
2018
2330
0.230
Why?
Healthcare Disparities
1
2008
324
0.220
Why?
Potentially Inappropriate Medication List
1
2024
14
0.220
Why?
Acute Kidney Injury
1
2006
130
0.220
Why?
Kidney Transplantation
1
2006
308
0.220
Why?
Bias
3
2014
107
0.220
Why?
Health Services
1
2004
81
0.220
Why?
Drug Administration Schedule
3
2014
283
0.220
Why?
Obesity
2
2013
1165
0.220
Why?
Health Knowledge, Attitudes, Practice
2
2009
725
0.220
Why?
Drug Therapy, Combination
5
2018
453
0.220
Why?
Tenofovir
1
2023
8
0.210
Why?
Socioeconomic Factors
5
2016
741
0.210
Why?
Adenine
1
2023
47
0.210
Why?
Blood Glucose
3
2018
461
0.210
Why?
Child Abuse
1
2004
89
0.210
Why?
Military Personnel
1
2004
97
0.210
Why?
Heart Transplantation
1
2004
162
0.210
Why?
Rivaroxaban
3
2023
19
0.210
Why?
Focus Groups
1
2024
288
0.210
Why?
Health Expenditures
1
2004
113
0.200
Why?
Acquired Immunodeficiency Syndrome
3
2009
137
0.200
Why?
Ivermectin
1
2022
11
0.200
Why?
Influenza Vaccines
1
2023
89
0.200
Why?
Intracranial Aneurysm
1
2006
345
0.190
Why?
Kidney
2
2023
412
0.190
Why?
Hypertension
1
2007
567
0.190
Why?
Varenicline
2
2011
11
0.190
Why?
Venous Thromboembolism
2
2013
139
0.190
Why?
International Classification of Diseases
2
2019
133
0.190
Why?
Medication Systems
1
2021
17
0.180
Why?
Pilot Projects
3
2017
914
0.180
Why?
Caregivers
1
2024
231
0.180
Why?
Delphi Technique
3
2019
82
0.180
Why?
Double-Blind Method
3
2023
714
0.180
Why?
Diuretics
1
2021
57
0.180
Why?
Calcium Channel Blockers
1
2021
56
0.180
Why?
Data Collection
2
2019
371
0.180
Why?
Pharmacy
1
2021
18
0.180
Why?
Ambulatory Care
3
2023
300
0.180
Why?
Patient Acceptance of Health Care
1
2025
449
0.180
Why?
Proton Pump Inhibitors
2
2019
34
0.180
Why?
Case-Control Studies
3
2013
1047
0.170
Why?
Medication Errors
1
2021
109
0.170
Why?
Safety Management
2
2012
137
0.170
Why?
Anti-Infective Agents
1
2022
143
0.170
Why?
Severity of Illness Index
2
2020
1475
0.170
Why?
Vaccines
1
2021
95
0.170
Why?
Drug Labeling
2
2012
23
0.170
Why?
Prevalence
5
2013
1249
0.170
Why?
Peripheral Arterial Disease
2
2020
155
0.170
Why?
Pharmacists
1
2021
122
0.160
Why?
Death Certificates
1
2019
9
0.160
Why?
Skin Neoplasms
1
2024
403
0.160
Why?
Prognosis
3
2014
1593
0.160
Why?
Patient Safety
2
2012
238
0.160
Why?
Vulnerable Populations
2
2013
84
0.160
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
33
0.160
Why?
Medicare
1
2023
598
0.160
Why?
Reminder Systems
1
2019
72
0.160
Why?
Canagliflozin
1
2018
5
0.150
Why?
Health Status
2
2016
424
0.150
Why?
Armed Conflicts
1
2018
3
0.150
Why?
Exposure to Violence
1
2018
5
0.150
Why?
Data Interpretation, Statistical
3
2015
190
0.150
Why?
Education
1
2018
68
0.150
Why?
Comparative Effectiveness Research
3
2013
45
0.150
Why?
Health Facilities
1
2018
42
0.150
Why?
Health Education
1
2019
182
0.150
Why?
Quality Control
1
2018
70
0.150
Why?
Cooperative Behavior
1
2019
210
0.150
Why?
Crime Victims
1
2018
31
0.150
Why?
Osteoporotic Fractures
1
2018
29
0.150
Why?
Multiple Chronic Conditions
1
2018
37
0.140
Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.140
Why?
Budesonide
2
2023
20
0.140
Why?
Metformin
2
2015
63
0.140
Why?
Practice Patterns, Physicians'
2
2021
683
0.140
Why?
Torture
2
2008
2
0.140
Why?
Respiratory Function Tests
2
2009
189
0.140
Why?
Population Surveillance
1
2018
194
0.140
Why?
Insulin Detemir
1
2016
1
0.140
Why?
Insulin Glargine
1
2016
2
0.140
Why?
Insulin, Long-Acting
1
2016
2
0.140
Why?
Liraglutide
1
2016
4
0.140
Why?
Observer Variation
1
2017
205
0.140
Why?
Medical Records
1
2017
133
0.140
Why?
Glucagon-Like Peptides
1
2016
3
0.140
Why?
Cross-Sectional Studies
3
2019
2370
0.140
Why?
Stress, Psychological
2
2014
442
0.140
Why?
Hormone Replacement Therapy
1
2016
28
0.130
Why?
Androgens
1
2016
47
0.130
Why?
Immunoglobulin Fc Fragments
1
2016
44
0.130
Why?
Thiamine Deficiency
2
2007
6
0.130
Why?
Antiretroviral Therapy, Highly Active
2
2006
93
0.130
Why?
China
2
2008
134
0.130
Why?
Drug Evaluation
1
2016
19
0.130
Why?
Widowhood
1
2016
4
0.130
Why?
Research
2
2015
188
0.130
Why?
Surge Capacity
1
2015
1
0.130
Why?
Hypoglycemia
1
2016
66
0.130
Why?
Registries
1
2019
795
0.130
Why?
Social Isolation
1
2016
29
0.130
Why?
Drug Interactions
2
2007
115
0.130
Why?
Insurance Claim Review
1
2015
72
0.120
Why?
Sensitivity and Specificity
3
2014
1090
0.120
Why?
Hospital Mortality
1
2020
839
0.120
Why?
Rosuvastatin Calcium
2
2005
3
0.120
Why?
Violence
2
2007
146
0.120
Why?
Checklist
1
2016
72
0.120
Why?
Comorbidity
1
2018
1076
0.120
Why?
Recombinant Fusion Proteins
1
2016
488
0.120
Why?
Altruism
1
2014
13
0.120
Why?
Adrenomedullin
1
2014
4
0.120
Why?
Publishing
1
2016
90
0.120
Why?
Multiple Myeloma
1
2019
325
0.120
Why?
Cognitive Dysfunction
1
2018
308
0.120
Why?
Protein Precursors
1
2014
75
0.110
Why?
Aspirin
1
2015
166
0.110
Why?
Health Services Needs and Demand
2
2007
204
0.110
Why?
Health Services Research
1
2015
265
0.110
Why?
Patient Compliance
2
2006
349
0.110
Why?
Phosphodiesterase 4 Inhibitors
1
2013
13
0.110
Why?
Bone Density
2
2018
129
0.110
Why?
Bibliometrics
1
2013
28
0.110
Why?
Dutasteride
1
2013
1
0.110
Why?
Pakistan
1
2013
14
0.110
Why?
Diabetes Mellitus
1
2018
515
0.110
Why?
Publications
1
2013
28
0.110
Why?
Prostatic Diseases
1
2013
9
0.110
Why?
Meditation
1
2014
54
0.110
Why?
Time Factors
3
2011
3586
0.110
Why?
Sitagliptin Phosphate
1
2013
2
0.110
Why?
Sex Workers
1
2013
17
0.110
Why?
Emergency Medicine
1
2015
181
0.110
Why?
Tetrabenazine
1
2013
1
0.100
Why?
Adrenergic Uptake Inhibitors
1
2013
14
0.100
Why?
Social Support
1
2016
355
0.100
Why?
Pyrazines
1
2013
33
0.100
Why?
Drug Recalls
1
2012
1
0.100
Why?
Affect
1
2014
122
0.100
Why?
Triazoles
1
2013
51
0.100
Why?
Risk Reduction Behavior
1
2013
120
0.100
Why?
Substance Abuse, Intravenous
1
2013
74
0.100
Why?
Therapeutic Equivalency
1
2012
16
0.100
Why?
Endpoint Determination
1
2012
24
0.100
Why?
Histamine H2 Antagonists
1
2012
10
0.100
Why?
Bayes Theorem
2
2023
109
0.100
Why?
Massachusetts
3
2025
2006
0.100
Why?
Neoplasms
2
2015
1239
0.100
Why?
Enterocolitis, Pseudomembranous
1
2012
34
0.100
Why?
MP3-Player
1
2011
2
0.100
Why?
Suicidal Ideation
1
2013
113
0.090
Why?
Emergency Service, Hospital
1
2019
1022
0.090
Why?
Platelet Aggregation Inhibitors
1
2013
211
0.090
Why?
Fluticasone
1
2011
16
0.090
Why?
Neuromuscular Diseases
1
2021
20
0.090
Why?
Huntington Disease
1
2013
146
0.090
Why?
Androstadienes
1
2011
39
0.090
Why?
Mental Disorders
2
2009
721
0.090
Why?
Health Care Rationing
2
2015
21
0.090
Why?
Survival Analysis
1
2012
553
0.090
Why?
Salmeterol Xinafoate
1
2010
7
0.090
Why?
Observation
1
2010
29
0.090
Why?
Reference Values
1
2011
324
0.090
Why?
Albuterol
1
2010
24
0.090
Why?
Patient Satisfaction
2
2011
410
0.090
Why?
Attitude of Health Personnel
2
2025
552
0.090
Why?
Biomechanical Phenomena
1
2021
242
0.090
Why?
Symptom Flare Up
1
2020
13
0.090
Why?
Symptom Assessment
1
2020
43
0.080
Why?
Needs Assessment
2
2015
187
0.080
Why?
Logistic Models
1
2013
1223
0.080
Why?
Quality Indicators, Health Care
1
2012
330
0.080
Why?
Program Evaluation
2
2011
472
0.080
Why?
Technology, Pharmaceutical
1
2009
19
0.080
Why?
Respiratory Aspiration
1
2009
5
0.080
Why?
Anti-Retroviral Agents
1
2009
73
0.080
Why?
Sodium Bicarbonate
1
2008
11
0.080
Why?
Latin America
1
2008
12
0.080
Why?
Africa
1
2008
21
0.080
Why?
Japan
1
2008
52
0.080
Why?
Bronchoscopy
1
2009
83
0.080
Why?
Russia
1
2008
53
0.080
Why?
Drug Discovery
1
2009
89
0.080
Why?
Foreign Bodies
1
2009
44
0.080
Why?
Taiwan
2
2021
8
0.080
Why?
Sarcoidosis, Pulmonary
1
2018
14
0.080
Why?
Thiamine
2
2007
18
0.080
Why?
Tibet
2
2006
2
0.080
Why?
Odds Ratio
2
2008
736
0.080
Why?
Government Regulation
1
2008
40
0.080
Why?
Scleroderma, Systemic
1
2018
20
0.080
Why?
Research Support as Topic
1
2008
39
0.080
Why?
Drug Industry
1
2008
39
0.080
Why?
Sex Factors
1
2021
933
0.070
Why?
Health Personnel
2
2018
339
0.070
Why?
India
1
2008
150
0.070
Why?
Kidney Function Tests
1
2008
35
0.070
Why?
Colorectal Neoplasms
1
2011
263
0.070
Why?
Nephrology
1
2008
15
0.070
Why?
Anti-HIV Agents
2
2006
153
0.070
Why?
Sulfonylurea Compounds
2
2020
13
0.070
Why?
Osteoporosis
1
2009
102
0.070
Why?
Recurrence
2
2012
601
0.070
Why?
Causality
1
2008
57
0.070
Why?
Cardiac Output, Low
1
2007
10
0.070
Why?
Disease Progression
2
2024
1120
0.070
Why?
Rwanda
1
2007
12
0.070
Why?
Postgastrectomy Syndromes
1
2007
4
0.070
Why?
Malabsorption Syndromes
1
2007
3
0.070
Why?
Anecdotes as Topic
1
2007
10
0.070
Why?
Toxins, Biological
1
2007
6
0.070
Why?
Patient Care Planning
1
2008
84
0.070
Why?
Internet
1
2011
449
0.070
Why?
Catheters, Indwelling
1
2008
66
0.070
Why?
New York City
1
2007
75
0.070
Why?
Public Policy
1
2008
37
0.070
Why?
Homicide
1
2007
26
0.070
Why?
Child, Preschool
2
2020
1776
0.070
Why?
Health Policy
2
2008
175
0.070
Why?
Homosexuality, Male
1
2007
38
0.070
Why?
Communicable Disease Control
1
2007
36
0.070
Why?
Kidney Diseases
1
2008
166
0.070
Why?
Catheterization, Central Venous
1
2008
81
0.070
Why?
Anxiety
2
2014
387
0.070
Why?
Theft
1
2006
2
0.070
Why?
Developed Countries
1
2006
16
0.070
Why?
Disease Susceptibility
1
2007
157
0.070
Why?
Educational Status
1
2008
264
0.070
Why?
Safety
1
2007
141
0.070
Why?
Communicable Diseases
1
2007
84
0.070
Why?
History, 21st Century
1
2007
164
0.070
Why?
Vascular Neoplasms
1
2006
15
0.070
Why?
Minority Groups
1
2008
135
0.070
Why?
HIV
1
2006
68
0.070
Why?
Infant Mortality
1
2006
19
0.070
Why?
Police
1
2006
35
0.070
Why?
Expert Systems
1
2006
4
0.070
Why?
Pregnancy
1
2013
2202
0.070
Why?
History, 20th Century
1
2007
227
0.070
Why?
Life Change Events
1
2006
65
0.070
Why?
Penicillins
1
2006
29
0.060
Why?
Guideline Adherence
1
2008
288
0.060
Why?
Likelihood Functions
1
2006
68
0.060
Why?
Ethics, Research
1
2006
20
0.060
Why?
Vasoconstriction
1
2006
21
0.060
Why?
Biomarkers
2
2014
1304
0.060
Why?
Lymphoma, Large B-Cell, Diffuse
1
2006
65
0.060
Why?
Endarterectomy, Carotid
1
2006
87
0.060
Why?
Recombinant Proteins
1
2008
688
0.060
Why?
Thrombosis
1
2008
182
0.060
Why?
Child Health Services
1
2006
60
0.060
Why?
AIDS Vaccines
1
2006
64
0.060
Why?
Maternal Health Services
1
2006
61
0.060
Why?
Decision Support Systems, Clinical
1
2006
64
0.060
Why?
Condoms
1
2005
47
0.060
Why?
Diabetic Nephropathies
1
2005
37
0.060
Why?
Horner Syndrome
1
2005
1
0.060
Why?
Patient Care Team
1
2008
328
0.060
Why?
Communism
1
2004
1
0.060
Why?
War Crimes
1
2004
2
0.060
Why?
Nutrition Disorders
1
2004
6
0.060
Why?
Interleukin-4 Receptor alpha Subunit
1
2024
1
0.060
Why?
Carotid Artery, Internal, Dissection
1
2005
15
0.060
Why?
Infant
2
2006
1481
0.060
Why?
Principle-Based Ethics
1
2004
2
0.060
Why?
Educational Measurement
1
2006
211
0.060
Why?
Poverty
1
2007
281
0.060
Why?
Cyclopropanes
2
2016
50
0.060
Why?
Psychology, Child
1
2004
7
0.060
Why?
Resource Allocation
1
2004
19
0.060
Why?
Rural Health
1
2004
15
0.060
Why?
Family Practice
1
2006
207
0.060
Why?
Health Planning
1
2004
29
0.060
Why?
Drug Utilization
1
2006
208
0.060
Why?
Education, Medical
1
2006
176
0.060
Why?
Total Quality Management
1
2004
56
0.060
Why?
Malaria, Vivax
1
2005
36
0.060
Why?
Child Advocacy
1
2004
7
0.060
Why?
Cyclosporine
1
2004
76
0.060
Why?
Drug Delivery Systems
1
2008
311
0.060
Why?
Morbidity
1
2004
110
0.060
Why?
Postoperative Care
1
2004
113
0.060
Why?
Tachycardia, Ventricular
1
2006
119
0.060
Why?
Cluster Analysis
1
2024
241
0.060
Why?
Gastric Bypass
1
2004
74
0.060
Why?
Medicaid
2
2019
334
0.050
Why?
Africa South of the Sahara
3
2009
16
0.050
Why?
Trust
1
2024
67
0.050
Why?
Pyridones
1
2023
37
0.050
Why?
Pragmatic Clinical Trials as Topic
1
2023
6
0.050
Why?
Factor Xa Inhibitors
1
2023
35
0.050
Why?
Physicians, Primary Care
1
2024
72
0.050
Why?
Fluvoxamine
1
2023
1
0.050
Why?
Students, Medical
1
2006
244
0.050
Why?
Injections, Subcutaneous
1
2023
69
0.050
Why?
Diagnosis, Differential
1
2006
930
0.050
Why?
Embolization, Therapeutic
1
2006
308
0.050
Why?
Mobile Applications
1
2024
129
0.050
Why?
Curriculum
1
2006
557
0.050
Why?
National Institutes of Health (U.S.)
1
2023
109
0.050
Why?
United States Agency for Healthcare Research and Quality
2
2012
30
0.050
Why?
Stents
1
2006
454
0.050
Why?
Antineoplastic Agents
1
2008
629
0.050
Why?
Immunosuppressive Agents
1
2004
365
0.050
Why?
Intention
1
2022
64
0.050
Why?
Infant, Newborn
1
2006
1281
0.050
Why?
Transcriptome
1
2024
338
0.050
Why?
Peripheral Vascular Diseases
1
2021
45
0.040
Why?
Liver
1
2005
795
0.040
Why?
Glucosides
1
2020
13
0.040
Why?
Pandemics
1
2025
614
0.040
Why?
Interviews as Topic
2
2016
481
0.040
Why?
Administrative Claims, Healthcare
1
2019
10
0.040
Why?
Tennessee
1
2019
16
0.040
Why?
Benzhydryl Compounds
1
2020
48
0.040
Why?
Clinical Competence
1
2004
684
0.040
Why?
Longitudinal Studies
1
2023
1189
0.040
Why?
Clinical Coding
1
2019
43
0.040
Why?
United Nations
2
2009
3
0.040
Why?
Government
1
2018
8
0.040
Why?
Bombs
1
2018
3
0.040
Why?
Syria
1
2018
15
0.040
Why?
Epidemiological Monitoring
1
2018
26
0.040
Why?
Mass Casualty Incidents
1
2018
31
0.040
Why?
Propensity Score
1
2018
144
0.040
Why?
Surveys and Questionnaires
2
2018
2513
0.040
Why?
Health Resources
1
2018
87
0.040
Why?
Predictive Value of Tests
1
2019
1022
0.030
Why?
Cyclohexanecarboxylic Acids
1
2015
8
0.030
Why?
Consensus Development Conferences as Topic
1
2015
13
0.030
Why?
Quetiapine Fumarate
1
2015
11
0.030
Why?
Selection Bias
1
2015
22
0.030
Why?
Neuralgia
1
2015
20
0.030
Why?
Amines
1
2015
29
0.030
Why?
Heparin
2
2008
110
0.030
Why?
gamma-Aminobutyric Acid
1
2015
70
0.030
Why?
Analgesics
1
2015
95
0.030
Why?
Triage
1
2015
108
0.030
Why?
Placebos
1
2013
68
0.030
Why?
Adaptation, Psychological
1
2016
259
0.030
Why?
Community-Acquired Infections
1
2014
92
0.030
Why?
Enoxaparin
1
2013
15
0.030
Why?
Emotions
1
2016
214
0.030
Why?
Proportional Hazards Models
1
2015
671
0.030
Why?
Heparin, Low-Molecular-Weight
1
2013
26
0.030
Why?
Bipolar Disorder
1
2015
242
0.030
Why?
Nasal Sprays
1
2012
2
0.030
Why?
Computer Graphics
1
2012
19
0.030
Why?
Nebulizers and Vaporizers
1
2012
36
0.030
Why?
International Normalized Ratio
1
2011
31
0.020
Why?
North Carolina
1
2011
68
0.020
Why?
Critical Care
1
2015
406
0.020
Why?
Terminology as Topic
1
2012
129
0.020
Why?
Pulmonary Embolism
1
2013
169
0.020
Why?
Computer-Assisted Instruction
1
2011
77
0.020
Why?
Patient Preference
1
2011
78
0.020
Why?
Health Literacy
1
2011
77
0.020
Why?
Voluntary Health Agencies
1
2009
4
0.020
Why?
Rape
1
2009
15
0.020
Why?
Body Weight
1
2011
368
0.020
Why?
Lipids
1
2011
300
0.020
Why?
Age Distribution
1
2009
248
0.020
Why?
Sodium Chloride
1
2008
60
0.020
Why?
Infusions, Intravenous
1
2008
165
0.020
Why?
Sexual Behavior
1
2009
189
0.020
Why?
Bhutan
1
2008
20
0.020
Why?
Animals
1
2006
19591
0.020
Why?
Myanmar
1
2007
8
0.020
Why?
Elephantiasis, Filarial
1
2007
9
0.020
Why?
Yellow Fever
1
2007
3
0.020
Why?
Colombia
1
2007
17
0.020
Why?
Leishmaniasis, Cutaneous
1
2007
15
0.020
Why?
Half-Life
1
2007
74
0.020
Why?
Chagas Disease
1
2007
34
0.020
Why?
Thrombocytopenia
1
2008
45
0.020
Why?
Hunger
1
2006
14
0.020
Why?
Time
1
2006
26
0.020
Why?
Social Welfare
1
2006
22
0.020
Why?
Leukocyte Common Antigens
1
2006
58
0.020
Why?
North America
1
2006
107
0.020
Why?
Coercion
1
2006
58
0.020
Why?
Fatal Outcome
1
2006
114
0.020
Why?
Lymphoma, B-Cell
1
2006
59
0.020
Why?
Multiple Organ Failure
1
2006
43
0.020
Why?
Clinical Trials Data Monitoring Committees
1
2006
4
0.020
Why?
Cambodia
1
2005
19
0.020
Why?
Confidentiality
1
2006
52
0.020
Why?
Self-Help Groups
1
2005
37
0.020
Why?
Prisons
1
2006
105
0.020
Why?
Attitude
1
2006
97
0.020
Why?
Quinine
1
2005
3
0.020
Why?
Chloroquine
1
2005
49
0.010
Why?
Drug Resistance, Microbial
1
2005
47
0.010
Why?
Informed Consent
1
2006
138
0.010
Why?
Doxycycline
1
2005
42
0.010
Why?
Antimalarials
1
2005
67
0.010
Why?
Erythrocytes
1
2005
146
0.010
Why?
Stress Disorders, Post-Traumatic
1
2008
380
0.010
Why?
Singh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (670)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_